Biphasic Ventilation Airway Management Clinical Trial
BVAM
Is Biphasic Ventilation Airway Management Utilizing Biphasic Cuirass Ventilation a Feasible Method to Provide Ventilation During the Apneic Phase for Patients Undergoing Emergent Rapid Sequence Intubation in the Emergency Department?
1 other identifier
interventional
15
1 country
1
Brief Summary
Investigators intend to determine if the use of Biphasic Cuirass Ventilation (BCV) improves patient safety (avoiding hypoxia) during emergency rapid sequence intubation .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2016
CompletedStudy Start
First participant enrolled
January 14, 2017
CompletedFirst Posted
Study publicly available on registry
February 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedFebruary 3, 2017
February 1, 2017
3 months
November 2, 2016
February 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite Primary Endpoint is the composite prevalence of any desaturation defined as SPO2 < 95% or Bradycardia, HR <60 beats per minute sustained for at least 30 seconds
The primary outcome measure is the composite prevalence of any desaturation defined as SPO2 \< 95% or Bradycardia, HR \<60 beats per minute sustained for at least 30 seconds, during and in the immediate post intubation (5 minutes after tracheal intubation is confirmed) period.
0 to 5 minutes after intubation
Secondary Outcomes (5)
Prevalence of post-paralytic Bag valve mask use
Time from paralytics administered until proper endotracheal tube placement is confirmed.
Waveform capnography pattern
Baseline to 30 minutes after intubation
Change in End-Tidal Carbon Dioxide (ETCO2) values
Period of time from acquiring baseline ETCO2 value to successful intubation.
Blood Pressure response to the BCV device
Baseline vital signs to 30 Minutes after intubation
SpO2 response to pre-oxygenation attempts BCV application
Baseline vital signs to 30 Minutes after intubation
Study Arms (1)
Biphasic Cuirass Ventilation
EXPERIMENTALPatients requiring emergent intubation in the Emergency Department will be provided ventilation during the apnic phase of intubation via the use of BCV.
Interventions
The RTX Respirator will be applied to the patient's chest to provide non-invasive ventilatory support using a Biphasic Cuirass Ventilation technology to increase the safe apnic period during intubation.
Eligibility Criteria
You may qualify if:
- Patients who present to the adult emergency department and require emergency intubation.
- Patient's primary language is English.
You may not qualify if:
- Cardiac arrest.
- Attending provider excludes patient as being at high risk for cardiac arrest or for any other reason.
- Patients who are known or reported to be pregnant pre-procedure.
- Patients in the custody of law enforcement.
- Inability to pre-oxygenate patient to an SPO2 equal to or greater than 95 percent prior to induction.
- Morbidly or Extremely obese patients defined by the NIH as BMI greater than 40.
- History of valvular heart disease.
- Presence of subclavian central line or pacemaker which impairs ability of shell to seal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center of Southern Nevada
Las Vegas, Nevada, 89102, United States
Related Publications (8)
Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012 Mar;59(3):165-75.e1. doi: 10.1016/j.annemergmed.2011.10.002. Epub 2011 Nov 3.
PMID: 22050948BACKGROUNDBodily JB, Webb HR, Weiss SJ, Braude DA. Incidence and Duration of Continuously Measured Oxygen Desaturation During Emergency Department Intubation. Ann Emerg Med. 2016 Mar;67(3):389-95. doi: 10.1016/j.annemergmed.2015.06.006. Epub 2015 Jul 9.
PMID: 26164643BACKGROUNDSakles JC, Chiu S, Mosier J, Walker C, Stolz U. The importance of first pass success when performing orotracheal intubation in the emergency department. Acad Emerg Med. 2013 Jan;20(1):71-8. doi: 10.1111/acem.12055.
PMID: 23574475BACKGROUNDBrimacombe J, Keller C. Who is at increased risk of aspiration? Br J Anaesth. 2005 Feb;94(2):251; author reply 251-2. doi: 10.1093/bja/aei511. No abstract available.
PMID: 15629910BACKGROUNDKamine TH, Papavassiliou E, Schneider BE. Effect of abdominal insufflation for laparoscopy on intracranial pressure. JAMA Surg. 2014 Apr;149(4):380-2. doi: 10.1001/jamasurg.2013.3024.
PMID: 24522521BACKGROUNDLi J, Murphy-Lavoie H, Bugas C, Martinez J, Preston C. Complications of emergency intubation with and without paralysis. Am J Emerg Med. 1999 Mar;17(2):141-3. doi: 10.1016/s0735-6757(99)90046-3.
PMID: 10102312BACKGROUNDBenumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology. 1997 Oct;87(4):979-82. doi: 10.1097/00000542-199710000-00034. No abstract available.
PMID: 9357902BACKGROUNDCorrado A, Gorini M, Melej R, Baglioni S, Mollica C, Villella G, Consigli GF, Dottorini M, Bigioni D, Toschi M, Eslami A. Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study. Intensive Care Med. 2009 Apr;35(4):648-55. doi: 10.1007/s00134-008-1352-9. Epub 2008 Nov 20.
PMID: 19020859BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
David E Slattery, MD
University Medical Center of Southern Nevada
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 2, 2016
First Posted
February 3, 2017
Study Start
January 14, 2017
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
February 3, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared